B+
Bull case
25%
Probability
Target price
$100.00
Analysis reference price unavailable
Analysis 2026-10-23 · RankAlpha Sentiment Codex
DXCM
DexComCNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
Q2 revenue grew 13% year over year to $1.308 billion, with non-GAAP operating margin of 25.1%; Dexcom also raised the midpoint of 2026 revenue guidance. CONNECT results offer a potential longer-term demand avenue, subject to commercial execution.
Posture
Mixed
Lead driver
Value
What changed
3 setup hits (3d) with net bullish as of 2026-10-26.
What can break
CONNECT clinical results and the Stelo app launch do not establish reimbursement coverage, adoption rates or incremental revenue. [#SEC-8K-2026-07-30]
Momentum
41
Value
57
Sentiment
52
Setup hits (3d)
3 · Net Bullish
AI TargetsBase $86.00 · Bull $100.00 · Bear $62.00Analysis 2026-10-23; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-26 • Vendor: Data Vendor v1
Scores
As of 2026-10-26 • Model: HYBRID_IC_RP
AI Memo
As of 2026-10-23 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-26
Investment thesis
As of 2026-10-26
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-26. Definitions
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Bullish
Target $97.08
Why
Momentum41 · Δ7d -25.6
Value57 · Δ7d +0.8
Sentiment52 · Δ7d +15.6
So what
Balanced signals (Net Bullish). Wait for confirmation before sizing up.
Confirming evidence
- • 3 setup hits (3d) with net bullish as of 2026-10-26.
- • Value remains the lead driver in the composite, 7D delta +0.8.
Contradictions & invalidation
- • CONNECT clinical results and the Stelo app launch do not establish reimbursement coverage, adoption rates or incremental revenue. [#SEC-8K-2026-07-30]
- • Full-year revenue and non-GAAP margin guidance depend on continued CGM demand and execution; Q3 progress has not yet been reported. [#SEC-8K-2026-07-30]
- • The Q3 print has not occurred.
Catalyst clock
2026-10-29
Third-quarter results are due October 29—not October 22
Lead driver: Value · See fundamentals
Momentum
41
8% active weight
Current posture
7d trendSoftening
Δ7d
-25.6
Δ21d
-36.7
Value
57
47% active weight
Current posture
7d trendFlat
Δ7d
+0.8
Δ21d
+0.7
Sentiment
52
45% active weight
Current posture
7d trendImproving
Δ7d
+15.6
Δ21d
+8.5
Why this grade
Composite grade C. Momentum 41.2 / Value 56.6 / Sentiment 51.7
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-10-23. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$86.00
Analysis reference price unavailable
Analysis 2026-10-23 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$62.00
Analysis reference price unavailable
Analysis 2026-10-23 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-26
Fundamentals (TTM)
As of 2026-10-26
Market Cap
$29.65B
Beta
1.49
Shares Out
377.36M
P/E (TTM)
38.2
P/S (TTM)
5.84
P/FCF (TTM)
24.85
Rev YoY
+13.1%
EPS YoY
+43.6%
Gross Margin
+63.6%
Op Margin
+22.9%
Net Debt
-$609M
Current Ratio
1.73
As of 2026-10-26 • Updated nightlySource: Internal modelMethods & Data